MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Pfizer

Închisă

SectorSănătate

24.31 -1.58

Rezumat

Modificarea prețului

24h

Curent

Minim

24.31

Maxim

24.86

Indicatori cheie

By Trading Economics

Venit

-4.1B

411M

Vânzări

63M

18B

P/E

Medie Sector

17.972

63.778

EPS

0.63

Randament dividend

6.79

Marjă de profit

2.314

Angajați

81,000

EBITDA

-4.3B

2.5B

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+23.81% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

6.79%

2.39%

Următoarele câștiguri

29 apr. 2025

Data viitoare de dividende

13 iun. 2025

Următoarea dată ex-dividende

8 mai 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-7.5B

144B

Deschiderea anterioară

25.89

Închiderea anterioară

24.31

Sentimentul știrilor

By Acuity

45%

55%

165 / 386 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Pfizer Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

19 mar. 2025, 07:34 UTC

Achiziții, Fuziuni, Preluări

Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion

18 mar. 2025, 17:26 UTC

Achiziții, Fuziuni, Preluări

Pfizer to Dispose of Remaining Shareholding in Haleon

4 feb. 2025, 18:52 UTC

Principalele dinamici ale pieței

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

4 feb. 2025, 14:58 UTC

Câștiguri
Principalele dinamici ale pieței

Pfizer Shares Rise on Better-Than-Expected 4Q

26 mar. 2025, 22:29 UTC

Top știri

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- 2nd Update

26 mar. 2025, 19:19 UTC

Top știri

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- Update

26 mar. 2025, 17:39 UTC

Top știri

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- WSJ

18 mar. 2025, 16:58 UTC

Achiziții, Fuziuni, Preluări

Haleon Intends to Cancel Purchased Ordinary Shares

18 mar. 2025, 16:57 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Off-Market Transaction Will Close at Same Time as or Following Settlement of Offering

18 mar. 2025, 16:56 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Off-Market Purchase Worth Approx GBP170M in Ordinary Shares

18 mar. 2025, 16:56 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Haleon Agreed to Carry out Off-Market Purchase From Pfizer

18 mar. 2025, 16:52 UTC

Achiziții, Fuziuni, Preluări

Haleon Takes Note of Announcement

18 mar. 2025, 16:50 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Haleon Won't Receive Any Net Proceeds From Offering

18 mar. 2025, 16:50 UTC

Achiziții, Fuziuni, Preluări

Citigroup: This Is Subject to Customary Closing Conditions

18 mar. 2025, 16:50 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Pfizer Will Receive All of Net Proceeds From Offering

18 mar. 2025, 16:49 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Bookbuilding Period May Close at Any Time on Short Notice

18 mar. 2025, 16:49 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Bookbuilding Period Will Commence Immediately

18 mar. 2025, 16:49 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Price Per Sale Share to Be Determined Through Accelerated Bookbuilding Process

18 mar. 2025, 16:48 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Pfizer Intends to Sell Ordinary Shares to Institutional Investors

18 mar. 2025, 16:47 UTC

Achiziții, Fuziuni, Preluări

Citigroup:: Amount Is Pfizer's Entire Residual Shareholding in Haleon

18 mar. 2025, 16:47 UTC

Achiziții, Fuziuni, Preluări

Citigroup: This Represents Approx 7.3% Stake in Haleon

18 mar. 2025, 16:46 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Pfizer Intends to Sell Approx 662M Ordinary Shares in Haleon

17 mar. 2025, 09:00 UTC

Top știri

Pfizer Has a New Playbook for Reviving Sales -- And It's Starting to Pay Off -- WSJ

28 feb. 2025, 12:00 UTC

Top știri

Drug Stocks Are the New Safe Bet in a Shaky Market -- Heard on the Street -- WSJ

14 feb. 2025, 11:38 UTC

Top știri
Câștiguri

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

14 feb. 2025, 11:30 UTC

Top știri
Câștiguri

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

5 feb. 2025, 12:00 UTC

Top știri

Merck Is Suffering From a Classic Pharma Problem -- Heard on the Street -- WSJ

4 feb. 2025, 19:34 UTC

Top știri

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 3rd Update

4 feb. 2025, 19:10 UTC

Top știri

Pfizer Falls on RFK's Progress Towards Confirmation Despite Good Earnings. Its CEO is Unbothered. -- Barrons.com

4 feb. 2025, 18:51 UTC

Top știri

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 2nd Update

Comparație

Modificare preț

Pfizer Așteptări

Obiectiv de preț

By TipRanks

23.81% sus

Prognoză pe 12 luni

Medie 30.58 USD  23.81%

Maxim 36 USD

Minim 27 USD

În baza a 15 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPfizer - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

15 ratings

6

Cumpărare

9

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

24.52 / 25.23Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

165 / 386 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.